Integrated machine learning-driven disulfidptosis profiling: CYFIP1 and EMILIN1 as therapeutic nodes in neuroblastoma.

Publication Year: 2024

DOI:
10.1007/s00432-024-05630-8

PMCID:
PMC10907485

PMID:
38427078

Journal Information

Full Title: J Cancer Res Clin Oncol

Abbreviation: J Cancer Res Clin Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"clinical data and rna sequencing data regarding nb patients were acquired from the gene expression omnibus (geo; https://www ncbi nlm nih gov/geo/ ) database with 498 samples (gse49710) included and set as the train dataset."

Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors have no relevant financial or non-financial interests to disclose. Consent for publicationWritten informed consent was obtained from patients’ parents for the inclusion of any potentially identifiable images or data in this article. Ethical approvalThe research involving human participants was reviewed and approved by the Ethics Committee of Zhujiang Hospital of Southern Medical University. Conflict of interest The authors have no relevant financial or non-financial interests to disclose."

Evidence found in paper:

"Funding This study was supported by the Guangdong Basic and Applied Basic Research Foundation of China (2019A1515011086)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025